Phosphagenics Signs Japanese License Option and R&D Alliance
Filed with ASX · · 2 pages · English
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne
- Response to an ASX Price Query
- Positive Results Phase 1B Study Transdermal Oxycodone Patch
- POH Global Agreement with Novartis Animal Health
- Phosphagenics Launches Australian Skincare Products
Later from Avecho Biotechnology
- Phosphagenics Expands Japanese Option to Oxycodone Patch
- Phosphagenics Expands Licence Agreement for Diclofenac Gel
- Phosphagenics Initiates Cattle Study
- Phosphagenics Completes Grower/Finisher Pig Study
- June 2016 Half-year Financial Report and Appendix 4D
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology